have performed whole-exome sequencing of tumor and normal tissues from GC patients and found that TP53 mutations were early drivers of metastasis and significantly associated with poor metastasis-free survival, but the relationship between TP53 mutations and GC liver metastasis was not clear (42). Here, TP53 is linked to gastric cancer.